Lataa...
Comparison of (18)F-Fluoro-L-DOPA, (18)F-Fluoro-Deoxyglucose, and (18)F-Fluorodopamine PET and (123)I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Context: Besides (123)I-metaiodobenzylguanidine (MIBG), positron emission tomography (PET) agents are available for the localization of paraganglioma (PGL), including (18)F-3,4-dihydroxyphenylalanine (DOPA), (18)F-fluoro-2-deoxy-d-glucose ((18)F-FDG), and (18)F-fluorodopamine ((18)F-FDA). Objective:...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Endocrine Society
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2795662/ https://ncbi.nlm.nih.gov/pubmed/19864450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-1248 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|